Literature DB >> 9616351

Tyrosine phosphorylation of platelet derived growth factor beta receptors in coronary artery lesions: implications for vascular remodelling after directional coronary atherectomy and unstable angina pectoris.

J Abe1, J Deguchi, Y Takuwa, K Hara, Y Ikari, T Tamura, M Ohno, K Kurokawa.   

Abstract

BACKGROUND: Growth factors such as platelet derived growth factor (PDGF) have been postulated to be important mediators of neointimal proliferation observed in atherosclerotic plaques and restenotic lesions following coronary interventions. Binding of PDGF to its receptor results in intrinsic receptor tyrosine kinase activation and subsequent cellular migration, proliferation, and vascular contraction. AIMS: To investigate whether the concentration of PDGF beta receptor tyrosine phosphorylation obtained from directional coronary atherectomy (DCA) samples correlate with atherosclerotic plaque burden, the ability of diseased vessels to remodel, coronary risk factors, and clinical events.
METHODS: DCA samples from 59 patients and 15 non-atherosclerotic left internal thoracic arteries (LITA) were analysed for PDGF beta receptor tyrosine phosphorylation content by receptor immunoprecipitation and antiphosphotyrosine western blot. The amount of PDGF beta receptor phosphorylation was analysed in relation to angiographic follow up data and clinical variables.
RESULTS: PDGF beta receptor tyrosine phosphorylation in the 59 DCA samples was greater than in the 15 non-atherosclerotic LITA (mean (SD) 0.84 (0.67) v 0.17 (0.08) over a control standard, p < 0.0001). As evaluated by stepwise regression analysis, incorporation of both PDGF beta receptor tyrosine phosphorylation and immediate gain correlated strongly (adjusted r2 = 0.579) with late loss, although PDGF beta receptor tyramine phosphorylation alone correlated poorly with late loss. Multivariate regression analysis of coronary risk factors and clinical events revealed unstable angina as the most significant correlate of PDGF beta receptor tyrosine phosphorylation (F value 20.009, p < 0.0001).
CONCLUSIONS: PDGF beta receptor tyrosine phosphorylation in atherosclerotic lesions is increased compared with non-atherosclerotic arterial tissues. The association of PDGF beta receptor tyrosine phosphorylation with immediate gain strongly correlates with vascular remodelling. PDGF beta receptor tyrosine phosphorylation correlates with unstable angina pectoris.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9616351      PMCID: PMC1728674          DOI: 10.1136/hrt.79.4.400

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  33 in total

1.  Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury.

Authors:  J S Powell; J P Clozel; R K Müller; H Kuhn; F Hefti; M Hosang; H R Baumgartner
Journal:  Science       Date:  1989-07-14       Impact factor: 47.728

2.  Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: a link between angiotensin II and intimal thickening.

Authors:  J Abe; J Deguchi; T Matsumoto; N Takuwa; M Noda; M Ohno; M Makuuchi; K Kurokawa; Y Takuwa
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

3.  Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma.

Authors:  P Libby; S J Warner; R N Salomon; L K Birinyi
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

4.  Two different subunits associate to create isoform-specific platelet-derived growth factor receptors.

Authors:  R A Seifert; C E Hart; P E Phillips; J W Forstrom; R Ross; M J Murray; D F Bowen-Pope
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

5.  Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization.

Authors:  J N Wilcox; K M Smith; L T Williams; S M Schwartz; D Gordon
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

6.  A new digital electronic caliper for measurement of coronary arterial stenosis: comparison with visual estimates and computer-assisted measurements.

Authors:  D P Scoblionko; B G Brown; S Mitten; J H Caldwell; J W Kennedy; E L Bolson; H T Dodge
Journal:  Am J Cardiol       Date:  1984-03-01       Impact factor: 2.778

7.  Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall.

Authors:  T B Barrett; E P Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

8.  Vasoconstriction: a new activity for platelet-derived growth factor.

Authors:  B C Berk; R W Alexander; T A Brock; M A Gimbrone; R C Webb
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

9.  Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions.

Authors:  K Rubin; A Tingström; G K Hansson; E Larsson; L Rönnstrand; L Klareskog; L Claesson-Welsh; C H Heldin; B Fellström; L Terracio
Journal:  Lancet       Date:  1988-06-18       Impact factor: 79.321

10.  Compensatory enlargement of human atherosclerotic coronary arteries.

Authors:  S Glagov; E Weisenberg; C K Zarins; R Stankunavicius; G J Kolettis
Journal:  N Engl J Med       Date:  1987-05-28       Impact factor: 91.245

View more
  4 in total

1.  Disruption of platelet-derived growth factor-dependent phosphatidylinositol 3-kinase and phospholipase Cγ 1 activity abolishes vascular smooth muscle cell proliferation and migration and attenuates neointima formation in vivo.

Authors:  Evren Caglayan; Marius Vantler; Olli Leppänen; Felix Gerhardt; Lenard Mustafov; Henrik Ten Freyhaus; Kai Kappert; Margarete Odenthal; Wolfram H Zimmermann; Michelle D Tallquist; Stephan Rosenkranz
Journal:  J Am Coll Cardiol       Date:  2011-06-21       Impact factor: 24.094

Review 2.  [Pathophysiologic significance of growth factors and new therapeutic concepts in cardiovascular disease].

Authors:  S Rosenkranz; M Böhm; A Kazlauskas
Journal:  Med Klin (Munich)       Date:  1999-09-15

3.  YAP1/TEAD1 upregulate platelet-derived growth factor receptor beta to promote vascular smooth muscle cell proliferation and neointima formation.

Authors:  Islam Osman; Kunzhe Dong; Xiuhua Kang; Luyi Yu; Fei Xu; Abu Shufian Ishtiaq Ahmed; Xiangqin He; Jian Shen; Guoqing Hu; Wei Zhang; Jiliang Zhou
Journal:  J Mol Cell Cardiol       Date:  2021-03-19       Impact factor: 5.763

4.  Regulation of the Pax6 : Pax6(5a) mRNA ratio in the developing mammalian brain.

Authors:  Jeni Pinson; John O Mason; T Ian Simpson; David J Price
Journal:  BMC Dev Biol       Date:  2005-07-19       Impact factor: 1.978

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.